Effect of Heparin on Recanalization in Acute Stroke Patients with Intra-Arterial Thrombi
- PMID: 26487926
- PMCID: PMC4591492
- DOI: 10.4081/ni.2015.5807
Effect of Heparin on Recanalization in Acute Stroke Patients with Intra-Arterial Thrombi
Abstract
Anticoagulant use, such as heparin, is usually contraindicated in acute stroke patients. We present a study of patients, who were treated with intravenous heparin after a stroke that were also found to have an intraluminal thrombus. Prior studies imply that recanalization is achieved with heparin; however heparin should only prevent thrombus propagation. Therefore it is unclear whether and how IV heparin can achieve recanalization of intraluminal thrombi in acute stroke patients. A retrospective review of all acute stroke patients from a single stroke center who received a therapeutic IV heparin infusion from 5/2006 to 9/2011 were included in the study. We compared patients who had complete/partial recanalization and/or improved flow versus those that did not, with both these groups on a standard intravenous heparin infusion protocol. Demographic data was compared between the groups. Average partial thromboplastin time (PTT) during heparin infusion, time between computed tomography angiographies (CTAs), time from stroke onset to receiving IV heparin, and vessel occluded were also compared between groups. Forty-one patients (19 female, 22 male) were included in the study with a total of 55 vessels (either carotid, middle cerebral artery, anterior cerebral artery, posterior cerebral artery/posterior circulation) having intraluminal thrombi; 31 patients had 41 vessels with either partial or complete recanalization of effected vessels, while 10 patients had 14 vessels that did not have at least one vessel recanalize while on heparin. Using t-test we noted that the average PTT between the vessels that had partial/complete recanalization group (61.74) and nonrecanalization group (66.30) was not statistical significantly different (P=0.37).The average time in days on heparin between vascular imaging studies (CTA/conventional angiogram) in the group of vessels with partial/complete recanalization (7.12 days) and the ones with no change (6.11 days) was not significantly different between the two groups (P=0.59). Patient's vessels receiving heparin for <24 hours versus those >24 hours did not significantly differ either (P=0.17). This study compares patient characteristics associated with recanalization of intraluminal thrombi in acute stroke patients on heparin. Recanalization of intraluminal thrombi are not associated with average PTT or duration on heparin.
Keywords: Heparin; recanalization; stroke; thrombus.
Conflict of interest statement
Conflict of interest: the authors declare no potential conflict of interest.
Figures
Similar articles
-
Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.JAMA. 2018 Sep 11;320(10):1017-1026. doi: 10.1001/jama.2018.12498. JAMA. 2018. PMID: 30208455 Free PMC article.
-
Acute anterior circulation stroke: recanalization using clot angioplasty.Can J Neurol Sci. 2006 May;33(2):217-22. doi: 10.1017/s0317167100005011. Can J Neurol Sci. 2006. PMID: 16736734
-
PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.Stroke. 1998 Jan;29(1):4-11. doi: 10.1161/01.str.29.1.4. Stroke. 1998. PMID: 9445320 Clinical Trial.
-
Recanalization therapies for acute ischemic stroke.Semin Neurol. 1998;18(4):471-84. doi: 10.1055/s-2008-1040900. Semin Neurol. 1998. PMID: 9932618 Review.
-
Endovascular Treatment of Thrombosis and Embolism.Adv Exp Med Biol. 2017;906:195-213. doi: 10.1007/5584_2016_116. Adv Exp Med Biol. 2017. PMID: 27664152 Review.
Cited by
-
A case of cerebral infarction during a hemodialysis procedure successfully treated with recombinant tissue plasminogen activator.CEN Case Rep. 2018 Nov;7(2):282-287. doi: 10.1007/s13730-018-0343-0. Epub 2018 Jun 12. CEN Case Rep. 2018. PMID: 29949116 Free PMC article.
-
Perioperative stroke: pathophysiology and management.Korean J Anesthesiol. 2018 Feb;71(1):3-11. doi: 10.4097/kjae.2018.71.1.3. Epub 2018 Feb 1. Korean J Anesthesiol. 2018. PMID: 29441169 Free PMC article. Review.
References
-
- Meyer JS. Localized changes in properties of the blood and effects of anticoagulant drugs in experimental cerebral infarction. N Engl J Med 1958;258:151-9. - PubMed
-
- Fisher CM. Cerebrovascular diseases: pathophysiology, diagnosis, and treatment. J Chron Dis 1958;8:419-47. - PubMed
-
- The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998;279:1265-72. - PubMed
-
- Benatar M. Heparin use in acute ischaemic stroke: does evidence change practice? QJM 2005;98:147-52. - PubMed
-
- Babikian VL, Kase CS, Pessin MS, et al. Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke 1989;20:1500-3. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources